Ambea (AMBEA) M&A Announcement summary

Deal rationale and strategic fit

• Acquisition of Validia enables entry into the Finnish social care market, making the group the only care provider with a strong presence in all four major Nordic countries.

• Validia is a market leader in severely disabled residential care, with a strong management team, cultural fit, and high care quality.

• The deal diversifies the customer and country base, adding about 20 Finnish well-being service counties and balancing the portfolio.

• Validia's platform enables future organic and acquisitive growth in Finland and adjacent care segments.

• The acquisition supports long-term growth, profitability, and strengthens the investment case for shareholders.

Financial terms and conditions

• Enterprise value of EUR 126 million (SEK 1,382 million), with Validia's 2024 net sales at EUR 127 million.

• Financed with a new EUR 90 million (SEK 990 million) term loan and 2 million treasury shares, subject to a 12-month lock-up.

• Transaction costs estimated at SEK 30 million (impacting 2025); integration and non-recurring costs at SEK 40 million (impacting 2025–2026).

• Post-transaction net debt/EBITDA expected at 2.8x, decreasing to 2–2.5x later in the year and remaining below target.

• Seller receives over 2% of shares and a 12-month lock-up, signaling ongoing commitment.

Synergies and expected cost savings

• Only minor cost synergies expected, mainly in procurement and IT, estimated at SEK 10 million.

• Operational excellence, digitalization, and best-practice sharing to drive quality improvements and innovation.

• Cross-country learning and leveraging Validia's RAI system and MONA care concept anticipated.